Docmode Health Technologies Limited IPO: Issue Price, Listing Gain and Share Price Now
Docmode Health Technologies Limited listed on 02-Feb-2024 at ₹180.75 against an issue price of ₹79 , a listing gain of +128.80%. It last traded at ₹33.1. This page is the record of that issue and what has happened to it since — reported figures only.
Docmode Health Technologies Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹79 |
| Listing price (listing-day close) | ₹180.75 |
| Listing gain | +128.80% |
| Price now | ₹33.1 |
| Change from issue price | -58.10% |
| Change from listing-day close | -81.69% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
Docmode Health Technologies Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹79 |
| Issue size | ₹6.71 Cr |
| Fresh issue | ₹6.37 Cr |
| Issue opened | 25-Jan-2024 |
| Issue closed | 30-Jan-2024 |
| Listed on | 02-Feb-2024 |
| Exchange | NSE SME |
| Segment | SME |
| Lead managers | Fedex Securities |
How the Docmode Health Technologies Limited IPO was subscribed
| Category | Subscription |
|---|---|
| NII | 194.90x |
| Retail | 230.38x |
| Total | 215.24x |
Docmode Health Technologies Limited today
| Figure | Value |
|---|---|
| Market capitalisation | ₹10.4 Cr |
| Return on capital employed | -0.3% |
| Return on equity | -21.7% |
| 52-week high | ₹125 |
| 52-week low | ₹30.6 |
| Sector | E-Learning |
Fundamentals are as of the desk's last harvest and move with the market.
- Docmode Health Technologies Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.